Clinical trials · Massachusetts
Chemotherapy-induced Peripheral Neuropathy clinical trials in Massachusetts
We’re tracking 3 recruiting chemotherapy-induced peripheral neuropathy studies with a site in Massachusetts, each written for real people, not researchers.
Recruiting studies in Massachusetts
- NCT07177820Recruiting
Virtual group acupuncture for chemo-related nerve pain
This study tests if virtual group acupuncture can help reduce nerve pain and numbness caused by chemotherapy (called CIPN). It is for people who finished taxane-based chemo for early-stage breast cancer and still have symptoms.
Charlestown, MassachusettsAges 18–80 - NCT06807294Recruiting
Tai chi for nerve damage from chemo
This study tests whether tai chi can help cancer survivors with nerve damage from chemotherapy. You will be randomly assigned to take tai chi classes or join a waitlist group, and the study tracks changes in balance, nerve pain, and quality of life.
Boston, MassachusettsAges 18 years+ - NCT07064798Recruiting
Cooling gloves and socks for nerve pain from chemo
This trial tests if wearing special cooling gloves and socks during chemotherapy can help prevent nerve damage, tingling, or numbness in your hands and feet. It is for people with breast or gynecologic cancer who are starting certain types of chemo that can cause these side effects.
Boston, MassachusettsAges 18 years+
Chemotherapy-induced Peripheral Neuropathy trials by city in Massachusetts
Where these studies are running in Massachusetts
Institutions with a site for the recruiting chemotherapy-induced peripheral neuropathy studies listed above.
- Dana-Farber Cancer Institute · 2 studies
- Massachusetts General Hospital
What taking part in a chemotherapy-induced peripheral neuropathy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Chemotherapy-induced Peripheral Neuropathy trials in other states
Common questions
- Are there chemotherapy-induced peripheral neuropathy clinical trials in Massachusetts?
- Yes. We're currently tracking 3 recruiting chemotherapy-induced peripheral neuropathy studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a chemotherapy-induced peripheral neuropathy study in Massachusetts?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Massachusetts to take part?
- Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a chemotherapy-induced peripheral neuropathy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New chemotherapy-induced peripheral neuropathy studies open in Massachusetts regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.